HSBC Knock-Out CHKP/ DE000HS6T8E9 /
04/10/2024 08:39:18 | Chg.+0.08 | Bid22:00:00 | Ask22:00:00 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.50EUR | +2.34% | - Bid Size: - |
- Ask Size: - |
Check Point Software... | 154.08 USD | 31/12/2078 | Call |
GlobeNewswire
03/09
Check Point Software Unveils New MSSP Portal for Partners: Vastly Simplifying Service Delivery and E...
GlobeNewswire
30/08
Carahsoft Sponsors 15th Annual Billington Cybersecurity Summit in Washington, D.C. on September 3-6...
GlobeNewswire
28/08
Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Pro...
GlobeNewswire
28/08
BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire
27/08
Check Point Software to Acquire Cyberint to Transform Security Operations and Expand Managed Threat ...
GlobeNewswire
14/08
Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
14/08
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire
13/08
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
13/08
Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma
GlobeNewswire
13/08
PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
GlobeNewswire
13/08
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
12/08
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024...
GlobeNewswire
12/08
Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
GlobeNewswire
12/08
Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
GlobeNewswire
08/08
ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
08/08
Bioatla Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
GlobeNewswire
08/08
PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting
GlobeNewswire
08/08
Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update